Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152413 | SCV000201442 | likely benign | not specified | 2014-08-13 | criteria provided, single submitter | clinical testing | Gln4356Gln in exon 45B of TTN: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 1/120 Colombian chr omosomes and 1/176 Nigerian chromosomes by the 1000 Genomes Project (dbSNP rs188 071134). |
Labcorp Genetics |
RCV000643700 | SCV000765387 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-12-22 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770105 | SCV000901531 | uncertain significance | Cardiomyopathy | 2016-05-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001569296 | SCV001793342 | likely benign | not provided | 2020-11-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444630 | SCV002682635 | likely benign | Cardiovascular phenotype | 2019-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001569296 | SCV004033832 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |